Search clinical trials for: 3% Diquafosol tetrasodium

Total 7359 results

He Eye Hospital
Santen Pharmaceutical(China) Co.,LTD

Not yet recruiting

Use of 3% Diquafosol Topical Ophthalmic Solution for Diabetic Dry Eye

Diabetic Eye Problems

China
He Eye Hospital

Not yet recruiting

Diquafosol vs Hyaluronic Acid for Diabetic Dry Eye

Diabetic Eye Problems

China
He Eye Hospital

Completed

Management of DE With IPL in Combination With DQS

Dry Eye

China
He Eye Hospital

Not yet recruiting

Diquafosol Ophthalmic Solution for Dry Eye Symptoms

Diabetic Eye Problems

China
He Eye Hospital

Not yet recruiting

Temperature on Evaporative Dry Eye

Dry Eye

China
Merck Sharp & Dohme LLC

Completed

A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic Solution

Dry Eye Disease
Merck Sharp & Dohme LLC

Completed

Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease

Dry Eye Disease
Merck Sharp & Dohme LLC

Completed

Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease

Dry Eye Disease
Merck Sharp & Dohme LLC

Completed

Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease

Dry Eye Disease
Merck Sharp & Dohme LLC

Completed

A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease

Dry Eye Disease
Merck Sharp & Dohme LLC

Completed

The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)

Dry Eye Disease
Merck Sharp & Dohme LLC

Terminated

A Double-masked, Randomized, Placebo-controlled,Pilot Study of Diquafosol Tetrasodium in Subjects Following Photorefractive Keratectomy (PRK)

Photorefractive Keratectomy
Peking University Third Hospital

Recruiting

The Effect of 3% Diquafosol Ophthalmic Solution on Visual Display Terminal-associated Dry Eye

Dry Eye Syndromes | Computer Vision Syndrome | Asthenopia

China
Merck Sharp & Dohme LLC

Completed

Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634)

Dry Eye Disease
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Efficacy and Safety of CKD-352

Dry Eye Disease

Korea, Republic of
Mun Wai Lee
Santen Oy

Recruiting

Dry Eye Management With 3% Diquafosol Before and After Cataract Surgery

Dry Eye

Malaysia
Taejoon Pharmaceutical Co., Ltd.

Recruiting

Comparing Efficacy and Safety of TJO-083 in Dry Eye Disease Patients

Dry Eye Syndromes

Korea, Republic of
Zhongshan Ophthalmic Center, Sun Yat-sen University

Recruiting

To Evaluate the Efficacy of Diquafosol Sodium in the Treatment of MGD in Different Treatment Pattern

Dry Eye | Meibomian Gland Dysfunction

China
Yonsei University

Completed

Effect of ADDE on Tear Interferometry

Dry Eye Syndromes | Tear

Korea, Republic of
Eisai Inc.

Completed

ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis

Severe Sepsis

United States, France, Poland, United Kingdom, Germany, Hong Kong, Taiwan, Spain, Switzerland, Argentina, Belgium, Israel, South Africa, Japan, Canada, Netherlands, Korea, Republic of, Australia, Chile, Brazil, Austria, Italy, Czechia, Portug...
Merck Sharp & Dohme LLC

Withdrawn

A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema

Macular Edema, Cystoid
Merck Sharp & Dohme LLC

Completed

A Study in Subjects With Retinal Detachment

Retinal Detachment
Merck Sharp & Dohme LLC

Terminated

Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment

Retinal Detachment

United States
Merck Sharp & Dohme LLC

Terminated

Study to Treat Uveitis Associated Macular Edema

Uveitis | Cystoid Macular Edema
Indonesia University
Santen Pharmaceutical Co., Ltd.

Recruiting

Effectiveness of Diquafosol Prophylactic Therapy to Prevent Dry Eye Disease for Cataract Surgery Patients in Indonesia

Dry Eye Disease

Indonesia
Merck Sharp & Dohme LLC

Completed

A Pharmacokinetic Evaluation Study in Healthy Volunteers

Healthy
Merck Sharp & Dohme LLC

Completed

Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung Disease

Cystic Fibrosis
Merck Sharp & Dohme LLC

Completed

A Study in Pediatric Patients With Cystic Fibrosis Lung Disease

Cystic Fibrosis

United States
Merck Sharp & Dohme LLC

Completed

A Pharmacokinetic Evaluation Study in Healthy Volunteers

Healthy
Merck Sharp & Dohme LLC
Cystic Fibrosis Foundation

Completed

Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease

Cystic Fibrosis
Merck Sharp & Dohme LLC

Terminated

Study 08-114 Open-label Extension of Study 08-110 - A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis Lung Disease (P08642) (DEFY)

Cystic Fibrosis
Merck Sharp & Dohme LLC

Terminated

Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung Disease

Cystic Fibrosis
Merck Sharp & Dohme LLC

Completed

A Study in Adult and Pediatric Patients With Cystic Fibrosis

Cystic Fibrosis
Yonsei University

Completed

Clinical Effects of Diquas-S for Patients With Dry Eye After Cataract Surgery

Dry Eye | Cataract Surgery

Korea, Republic of
Merck Sharp & Dohme LLC

Completed

Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease

Cystic Fibrosis

United States, Australia, Canada, New Zealand
University Health Network, Toronto

Recruiting

Use of Tetrasodium EDTA Catheter Lock Solution for Patients on HTPN

Catheter Complications

Canada
Merck Sharp & Dohme LLC

Completed

A Safety and Tolerability Study of Denufosol in 2-4 Year Olds (REACH-1)

Cystic Fibrosis
Merck Sharp & Dohme LLC

Completed

Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease

Cystic Fibrosis
Soonchunhyang University Hospital

Completed

Clinical Effects and Safety of 3% Diquafosol After Cataract Surgery

Dry Eye Syndromes
Boston Children's Hospital
SterileCare Inc.

Enrolling by invitation

Compassionate-Use of 4% T-EDTA Lock Solution for Central Venous Lines of Pediatric PN Patients

Central Line Complication | Central Line-associated Bloodstream Infection (CLABSI)

United States
Eastern Mediterranean University

Completed

Effect Of Meal Frequency On Weight Loss And Body Composition Of Obese And Overweight Women

Overweight and Obesity

Cyprus
Santen Pharmaceutical Co., Ltd.

Completed

Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

Dry Eye

Singapore, China
Edwards Lifesciences

Active, not recruiting

EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis (EARLY TAVR)

Heart Diseases | Aortic Stenosis, Severe

United States, Canada
Third Affiliated Hospital, Sun Yat-Sen University

Unknown

Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control Trial

Chronic Hepatitis B

China
Edwards Lifesciences

Active, not recruiting

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR (PROGRESS)

Aortic Valve Stenosis | Aortic Stenosis, Calcific

United States, Australia, Japan, Canada, Netherlands, Switzerland
University of Aarhus
Steno Diabetes Center Aarhus, Aarhus University Hospital, Denmark; Department...

Completed

Pre-meals of 3-hydroxybutyrate in Type 2 Diabetes (PreKetone)

Ketosis | Postprandial Hyperglycemia | Glucose Metabolism Disorders (Including Diabetes Mellitus)

Denmark
Edwards Lifesciences

Recruiting

COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

Pulmonary Valve Insufficiency | Complex Congenital Heart Defect | Dysfunctional RVOT Conduit | Pulmonary Valve Degeneration

United States
University of Massachusetts, Worcester

Withdrawn

Asthma Exacerbation and Helium-3 MRI

Asthma Exacerbation

United States
Assiut University

Completed

Galectin-3 and Placenta Accreta

Placenta Accreta

Egypt
Vibeke Moen

Completed

Do Changes in Plasma Osmolality Influence Ventilation? (OSM)

Hypernatraemia | Hyponatraemia

Sweden

Search clinical trials for: 3% Diquafosol tetrasodium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations